vs
Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and NEW JERSEY RESOURCES CORP (NJR). Click either name above to swap in a different company.
NEW JERSEY RESOURCES CORP is the larger business by last-quarter revenue ($939.4M vs $829.0M, roughly 1.1× Acadia Healthcare Company, Inc.). NEW JERSEY RESOURCES CORP runs the higher net margin — 23.3% vs 0.5%, a 22.8% gap on every dollar of revenue. On growth, Acadia Healthcare Company, Inc. posted the faster year-over-year revenue change (7.5% vs -33.0%). Over the past eight quarters, NEW JERSEY RESOURCES CORP's revenue compounded faster (111.6% CAGR vs 2.0%).
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
New Jersey Resources is an energy services holding company based in Wall Township, New Jersey. It is a Fortune 1000 company, and a member of the Forbes Platinum 400. New Jersey Natural Gas is its principal subsidiary.
ACHC vs NJR — Head-to-Head
Income Statement — Q1 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $829.0M | $939.4M |
| Net Profit | $4.5M | $218.9M |
| Gross Margin | — | — |
| Operating Margin | — | 32.0% |
| Net Margin | 0.5% | 23.3% |
| Revenue YoY | 7.5% | -33.0% |
| Net Profit YoY | -50.8% | 7.2% |
| EPS (diluted) | $0.05 | $2.16 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $829.0M | $939.4M | ||
| Q4 25 | $821.5M | $440.9M | ||
| Q3 25 | $851.6M | $188.3M | ||
| Q2 25 | $869.2M | $234.8M | ||
| Q1 25 | $770.5M | $569.2M | ||
| Q4 24 | $774.2M | $359.0M | ||
| Q3 24 | $815.6M | $265.7M | ||
| Q2 24 | $796.0M | $209.9M |
| Q1 26 | $4.5M | $218.9M | ||
| Q4 25 | $-1.2B | $122.5M | ||
| Q3 25 | $36.2M | $15.1M | ||
| Q2 25 | $30.1M | $-15.1M | ||
| Q1 25 | $8.4M | $204.3M | ||
| Q4 24 | $32.6M | $131.3M | ||
| Q3 24 | $68.1M | $91.1M | ||
| Q2 24 | $78.5M | $-11.6M |
| Q1 26 | — | 32.0% | ||
| Q4 25 | -142.4% | 40.6% | ||
| Q3 25 | 4.7% | 21.5% | ||
| Q2 25 | 5.8% | -0.5% | ||
| Q1 25 | 1.7% | 49.2% | ||
| Q4 24 | 4.9% | 52.8% | ||
| Q3 24 | 12.1% | 55.0% | ||
| Q2 24 | 13.4% | 2.8% |
| Q1 26 | 0.5% | 23.3% | ||
| Q4 25 | -143.3% | 27.8% | ||
| Q3 25 | 4.3% | 8.0% | ||
| Q2 25 | 3.5% | -6.4% | ||
| Q1 25 | 1.1% | 35.9% | ||
| Q4 24 | 4.2% | 36.6% | ||
| Q3 24 | 8.4% | 34.3% | ||
| Q2 24 | 9.9% | -5.5% |
| Q1 26 | $0.05 | $2.16 | ||
| Q4 25 | $-12.98 | $1.21 | ||
| Q3 25 | $0.40 | $0.15 | ||
| Q2 25 | $0.33 | $-0.15 | ||
| Q1 25 | $0.09 | $2.02 | ||
| Q4 24 | $0.36 | $1.31 | ||
| Q3 24 | $0.74 | $0.91 | ||
| Q2 24 | $0.85 | $-0.12 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $158.5M | — |
| Total DebtLower is stronger | $2.5B | — |
| Stockholders' EquityBook value | $2.0B | — |
| Total Assets | $5.5B | — |
| Debt / EquityLower = less leverage | 1.29× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $158.5M | — | ||
| Q4 25 | $133.2M | $2.4M | ||
| Q3 25 | $118.7M | $591.0K | ||
| Q2 25 | $131.4M | $931.0K | ||
| Q1 25 | $91.2M | $83.7M | ||
| Q4 24 | $76.3M | $1.9M | ||
| Q3 24 | $82.1M | $1.0M | ||
| Q2 24 | $77.2M | $22.4M |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | $3.3B | ||
| Q3 25 | $2.3B | $3.3B | ||
| Q2 25 | $2.3B | $3.0B | ||
| Q1 25 | $2.2B | $3.0B | ||
| Q4 24 | $2.0B | $3.0B | ||
| Q3 24 | $1.9B | $2.9B | ||
| Q2 24 | $1.8B | $2.8B |
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $2.5B | ||
| Q3 25 | $3.1B | $2.4B | ||
| Q2 25 | $3.1B | $2.4B | ||
| Q1 25 | $3.0B | $2.5B | ||
| Q4 24 | $3.1B | $2.3B | ||
| Q3 24 | $3.0B | $2.2B | ||
| Q2 24 | $3.0B | $2.1B |
| Q1 26 | $5.5B | — | ||
| Q4 25 | $5.5B | $7.9B | ||
| Q3 25 | $6.4B | $7.6B | ||
| Q2 25 | $6.3B | $7.3B | ||
| Q1 25 | $6.1B | $7.3B | ||
| Q4 24 | $6.0B | $7.2B | ||
| Q3 24 | $5.9B | $7.0B | ||
| Q2 24 | $5.7B | $6.8B |
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | 1.32× | ||
| Q3 25 | 0.74× | 1.36× | ||
| Q2 25 | 0.74× | 1.25× | ||
| Q1 25 | 0.72× | 1.20× | ||
| Q4 24 | 0.64× | 1.29× | ||
| Q3 24 | 0.62× | 1.31× | ||
| Q2 24 | 0.62× | 1.30× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $61.5M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 13.78× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $26.7M | ||
| Q3 25 | $73.2M | $81.2M | ||
| Q2 25 | $133.5M | $-28.9M | ||
| Q1 25 | $11.5M | $423.0M | ||
| Q4 24 | $116.7M | $-9.0M | ||
| Q3 24 | $163.1M | $64.5M | ||
| Q2 24 | $171.1M | $24.3M |
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | — | ||
| Q3 25 | $-63.0M | — | ||
| Q2 25 | $-34.2M | — | ||
| Q1 25 | $-163.2M | — | ||
| Q4 24 | $-86.8M | — | ||
| Q3 24 | $-27.1M | — | ||
| Q2 24 | $16.9M | — |
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | — | ||
| Q3 25 | -7.4% | — | ||
| Q2 25 | -3.9% | — | ||
| Q1 25 | -21.2% | — | ||
| Q4 24 | -11.2% | — | ||
| Q3 24 | -3.3% | — | ||
| Q2 24 | 2.1% | — |
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | — | ||
| Q3 25 | 16.0% | — | ||
| Q2 25 | 19.3% | — | ||
| Q1 25 | 22.7% | — | ||
| Q4 24 | 26.3% | — | ||
| Q3 24 | 23.3% | — | ||
| Q2 24 | 19.4% | — |
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | 0.22× | ||
| Q3 25 | 2.02× | 5.39× | ||
| Q2 25 | 4.43× | — | ||
| Q1 25 | 1.37× | 2.07× | ||
| Q4 24 | 3.58× | -0.07× | ||
| Q3 24 | 2.39× | 0.71× | ||
| Q2 24 | 2.18× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
NJR
| Utility | $640.9M | 68% |
| Nonutility | $298.5M | 32% |
